Procalcitonin: present and future.

  title={Procalcitonin: present and future.},
  author={H H Liu and Jiquan Guo and Yaoguo Geng and Lishan Su},
  journal={Irish journal of medical science},
  volume={184 3},
Critically ill patients are frequently at risk of sepsis or inflammatory conditions. Procalcitonin (PCT) is a biomarker for critically ill patients to differentiate sepsis from non-infectious triggers of the systemic inflammatory response syndrome. It has been recently shown that PCT is a valuable tool to guide antibiotic treatment in patients with bacteria infections. However, PCT is also less than a universal and perfect biomarker, and its physiologic role remains unknown. An increase in PCT… CONTINUE READING